Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 10Peritoneal Neoplasms 4Endometrial Neoplasms 4Uterine Cervical Neoplasms 3Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Carcinoma, Ovarian Epithelial 2Uterine Neoplasms 1Ovarian Cysts 1Obesity, Morbid 1Genital Neoplasms, Female 1Genital Diseases, Female 1Endometrial Adenocarcinoma 1Cholangiocarcinoma 1Breast Neoplasms 1Appendiceal Neoplasms 1Adnexal Diseases 1

Interventions

pembrolizumab 3Paclitaxel 3Carboplatin 3niraparib 2anlotinib 2Pemetrexed 2Palliative Care 2Interviews as Topic 2Gemcitabine 2Educational Status 2Bevacizumab 2temsirolimus 1relacorilant 1olaparib 1nilotinib 1liposomal doxorubicin 1lenvatinib 1Watchful Waiting 1Transurethral Resection of Prostate 1Topotecan 1Therapeutic Touch 1Radiotherapy 1Pregnancy Tests 1Ocoxin 1Nivolumab 1Methods 1Laparoscopy 1Human Papillomavirus DNA Tests 1Fulvestrant 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genital Neoplasms, Female × Laparoscopy × Gynecologic × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡